Platelets and heart failure

被引:104
作者
Chung, Irene [1 ]
Lip, Gregory Y. H. [1 ]
机构
[1] Univ Birmingham, City Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
关键词
platelet activation; heart failure; CD40L; P-selectin; antiplatelet therapy;
D O I
10.1093/eurheartj/ehl305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure is associated with increased risk of venous thromboembolism, stroke, and sudden death. Platelet abnormalities have been well described in heart failure but the significance of platelets in contributing to the thromboembolic complications of heart failure remains uncertain. Furthermore, the role of antiplatelet agents in heart failure remains unclear. This review will focus on platelet activation and the role of platelet dysfunction in heart failure, with particular regard to pathophysiology and outcome. The effects of heart failure therapeutics on platelet function and antiplatelet therapy in heart failure will also be discussed.
引用
收藏
页码:2623 / 2631
页数:9
相关论文
共 72 条
[61]   Evaluating the benefits of glycoprotein, IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes [J].
Srichai, MB ;
Jaber, WA ;
Prior, DL ;
Marso, SP ;
Houghtaling, PL ;
Menon, V ;
Simoons, ML ;
Harrington, RA ;
Hochman, JS .
AMERICAN HEART JOURNAL, 2004, 147 (01) :84-90
[62]   The current cost of heart failure to the National Health Service in the UK [J].
Stewart, S ;
Jenkins, A ;
Buchan, S ;
McGuire, A ;
Capewell, S ;
McMurray, JJJV .
EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :361-371
[63]   Enhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failure [J].
Stumpf, C ;
Lehner, C ;
Eskafi, S ;
Raaz, D ;
Yilmaz, A ;
Ropers, S ;
Schmeisser, A ;
Ludwig, J ;
Daniel, WG ;
Garlichs, CD .
EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (05) :629-637
[64]   Increased nitric oxide in proportion to the severity of heart failure in patients with dilated cardiomyopathy -: Close correlation of tumor necrosis factor-α with systemic and local production of nitric oxide [J].
Sugamori, T ;
Ishibashi, Y ;
Shimada, T ;
Takahashi, N ;
Sakane, T ;
Ohata, S ;
Kunizawa, Y ;
Inoue, S ;
Nakamura, K ;
Ohta, Y ;
Shimizu, H ;
Katoh, H ;
Oyake, N ;
Murakami, Y ;
Hashimoto, M .
CIRCULATION JOURNAL, 2002, 66 (07) :627-632
[65]   EFFECTS OF ANGIOTENSIN-II AND ENDOTHELIN-L ON PLATELET-AGGREGATION AND CYTOSOLIC PH AND FREE CA2+ CONCENTRATIONS IN ESSENTIAL-HYPERTENSION [J].
TOUYZ, RM ;
SCHIFFRIN, EL .
HYPERTENSION, 1993, 22 (06) :853-862
[66]   Soluble CD40 ligand in acute and chronic heart failure [J].
Ueland, T ;
Aukrust, P ;
Yndestad, A ;
Otterdal, K ;
Froland, SS ;
Dickstein, K ;
Kjekshus, J ;
Gullestad, L ;
Damåis, JK .
EUROPEAN HEART JOURNAL, 2005, 26 (11) :1101-1107
[67]   Soluble CD40L -: Risk prediction after acute coronary syndromes [J].
Varo, N ;
de Lemos, JA ;
Libby, P ;
Morrow, DA ;
Murphy, SA ;
Nuzzo, R ;
Gibson, CM ;
Cannon, CP ;
Braunwald, E ;
Schönbeck, U .
CIRCULATION, 2003, 108 (09) :1049-1052
[68]  
WEBER KT, 1995, CARDIOL REV, V3, P53
[69]   PLATELET ALPHA-2 ADRENORECEPTORS IN CHRONIC CONGESTIVE HEART-FAILURE [J].
WEISS, RJ ;
TOBES, M ;
WERTZ, CE ;
SMITH, CB .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (01) :101-105
[70]   THE COAGULATION SYSTEM IS ACTIVATED IN IDIOPATHIC CARDIOMYOPATHY [J].
YAMAMOTO, K ;
IKEDA, U ;
FURUHASHI, K ;
IROKAWA, M ;
NAKAYAMA, T ;
SHIMADA, K .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (07) :1634-1640